mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
1 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
1 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |